BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 27048405)

  • 1. Higher diagnostic accuracy and cost-effectiveness using procalcitonin in the treatment of emergency medicine patients with fever (The HiTEMP study): a multicenter randomized study.
    van der Does Y; Limper M; Schuit SC; Poley MJ; van Rosmalen J; Ramakers C; Patka P; van Gorp EC; Rood PP
    BMC Emerg Med; 2016 Apr; 16():17. PubMed ID: 27048405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procalcitonin-guided antibiotic therapy in patients with fever in a general emergency department population: a multicentre non-inferiority randomized clinical trial (HiTEMP study).
    van der Does Y; Limper M; Jie KE; Schuit SCE; Jansen H; Pernot N; van Rosmalen J; Poley MJ; Ramakers C; Patka P; van Gorp ECM; Rood PPM
    Clin Microbiol Infect; 2018 Dec; 24(12):1282-1289. PubMed ID: 29870855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker.
    Fernández Lopez A; Luaces Cubells C; García García JJ; Fernández Pou J;
    Pediatr Infect Dis J; 2003 Oct; 22(10):895-903. PubMed ID: 14551491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein, procalcitonin and the lab-score for detecting serious bacterial infections in febrile children at the emergency department: a prospective observational study.
    Nijman RG; Moll HA; Smit FJ; Gervaix A; Weerkamp F; Vergouwe Y; de Rijke YB; Oostenbrink R
    Pediatr Infect Dis J; 2014 Nov; 33(11):e273-9. PubMed ID: 25093971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.
    Westwood M; Ramaekers B; Whiting P; Tomini F; Joore M; Armstrong N; Ryder S; Stirk L; Severens J; Kleijnen J
    Health Technol Assess; 2015 Nov; 19(96):v-xxv, 1-236. PubMed ID: 26569153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procalcitonin and C-reactive protein as diagnostic markers of severe bacterial infections in febrile infants and children in the emergency department.
    Andreola B; Bressan S; Callegaro S; Liverani A; Plebani M; Da Dalt L
    Pediatr Infect Dis J; 2007 Aug; 26(8):672-7. PubMed ID: 17848876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients--calculated sample size: 1816 patients.
    Assink-de Jong E; de Lange DW; van Oers JA; Nijsten MW; Twisk JW; Beishuizen A
    BMC Infect Dis; 2013 Apr; 13():178. PubMed ID: 23590389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additional value of procalcitonin for diagnosis of infection in patients with fever at the emergency department.
    de Kruif MD; Limper M; Gerritsen H; Spek CA; Brandjes DP; ten Cate H; Bossuyt PM; Reitsma PH; van Gorp EC
    Crit Care Med; 2010 Feb; 38(2):457-63. PubMed ID: 20083920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying patients with bacterial infections using a combination of C-reactive protein, procalcitonin, TRAIL, and IP-10 in the emergency department: a prospective observational cohort study.
    van der Does Y; Rood PPM; Ramakers C; Schuit SCE; Patka P; van Gorp ECM; Limper M
    Clin Microbiol Infect; 2018 Dec; 24(12):1297-1304. PubMed ID: 30268671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of procalcitonin for hospitalised children with acute pyelonephritis presenting to the paediatric emergency department.
    Chen SM; Chang HM; Hung TW; Chao YH; Tsai JD; Lue KH; Sheu JN
    Emerg Med J; 2013 May; 30(5):406-10. PubMed ID: 22645218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markers that predict serious bacterial infection in infants under 3 months of age presenting with fever of unknown origin.
    Olaciregui I; Hernández U; Muñoz JA; Emparanza JI; Landa JJ
    Arch Dis Child; 2009 Jul; 94(7):501-5. PubMed ID: 19158133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procalcitonin as a marker of bacteremia in children with fever and a central venous catheter presenting to the emergency department.
    Kasem AJ; Bulloch B; Henry M; Shah K; Dalton H
    Pediatr Emerg Care; 2012 Oct; 28(10):1017-21. PubMed ID: 23023470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum procalcitonin measurement as diagnostic and prognostic marker in febrile adult patients presenting to the emergency department.
    Hausfater P; Juillien G; Madonna-Py B; Haroche J; Bernard M; Riou B
    Crit Care; 2007; 11(3):R60. PubMed ID: 17521430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procalcitonin-based therapeutic strategy to reduce antibiotic use in patients after cardiac surgery: a randomized controlled trial.
    Maravić-Stojković V; Lausević-Vuk L; Jović M; Ranković A; Borzanović M; Marinković J
    Srp Arh Celok Lek; 2011; 139(11-12):736-42. PubMed ID: 22338468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.
    Schuetz P; Christ-Crain M; Thomann R; Falconnier C; Wolbers M; Widmer I; Neidert S; Fricker T; Blum C; Schild U; Regez K; Schoenenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Mueller B;
    JAMA; 2009 Sep; 302(10):1059-66. PubMed ID: 19738090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: a randomized noninferiority trial.
    Verduri A; Luppi F; D'Amico R; Balduzzi S; Vicini R; Liverani A; Ruggieri V; Plebani M; Barbaro MP; Spanevello A; Canonica GW; Papi A; Fabbri LM; Beghè B;
    PLoS One; 2015; 10(3):e0118241. PubMed ID: 25760346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of procalcitonin level in community-acquired pneumonia in the ED.
    Park JH; Wee JH; Choi SP; Oh SH
    Am J Emerg Med; 2012 Sep; 30(7):1248-54. PubMed ID: 22030193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of procalcitonin on the management of children aged 1 to 36 months presenting with fever without source: a randomized controlled trial.
    Manzano S; Bailey B; Girodias JB; Galetto-Lacour A; Cousineau J; Delvin E
    Am J Emerg Med; 2010 Jul; 28(6):647-53. PubMed ID: 20637377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between white blood cell count, procalcitonin and C reactive protein as diagnostic and prognostic biomarkers of infection or sepsis in patients presenting to emergency department.
    Magrini L; Gagliano G; Travaglino F; Vetrone F; Marino R; Cardelli P; Salerno G; Di Somma S
    Clin Chem Lab Med; 2014 Oct; 52(10):1465-72. PubMed ID: 24803611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and Prognostic Utility of Procalcitonin in Patients Presenting to the Emergency Department with Dyspnea.
    Alba GA; Truong QA; Gaggin HK; Gandhi PU; De Berardinis B; Magrini L; Bajwa EK; Di Somma S; Januzzi JL;
    Am J Med; 2016 Jan; 129(1):96-104.e7. PubMed ID: 26169892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.